In 2021, the market for Hemodialysis and Peritoneal Dialysis worldwide was worth $ 17 billion US dollars. AMR Group projects that the market will reach US$ 24 billion by 2031, growing at a CAGR of 6.3 percent between 2022 and 2031.
Industry Overview
Hemodialysis is a method of treatment for people with renal failure that involves taking wastes, salts, and liquids out of the patient's blood. The peritoneum of the abdominal cavity performs the cleansing function of the kidney during peritoneal dialysis. To administer the dialysis treatment successfully, dialyzers, bloodlines, catheters, and dialysates are needed. The market is being driven by factors such the rising prevalence of kidney diseases, diabetes, and hypertension, the rising number of dialysis facilities; initiatives for chronic renal care, and the lack of kidney transplants.
Hemodialysis is the removal of extra and waste chemicals and fluids from the body using a hemodialyzer. Dialysate, which resembles physiological fluid with the exception of the presence of pollutants, comes into contact with the blood as it passes through the filter. A rigorous treatment schedule and minimal room for patient mobility, time, or transportation make this type of dialysis quite demanding. Moreover, it necessitates the development and maintenance of vascular access, which may entail the use of a dialysis catheter or the development of an AV fistula or graft in the arm or groin to access the high blood flows required for dialysis.
Market Dynamics
There has been an increase in kidney-related illnesses and issues with kidney transplants in the hemodialysis and peritoneal dialysis markets. According to a study released by the National Kidney Foundation, Inc., renal disease affects more than one in seven Americans. The percentage of adults in the United States who are 18 or older and who have chronic kidney disease, broken down by gender, is shown in the following graph (CKD). Other market-driving variables include the rise in chronic diseases and lifestyle-related illnesses like obesity, diabetes, and hypertension. The majority of ESRD patients receive hemodialysis or peritoneal dialysis. Increased healthcare spending, high disposable income, an increase in the proportion of older people, improvements in the healthcare infrastructure, and an increase in the number of dialysis facilities.
Hence, profitable technology developments and product launches continue. Nonetheless, the CDC estimates that there are more than 37 million people worldwide who have CKD. However, the same source states that CKD is more prevalent in those over 65 and can result in dialysis. Infections, hypotension, fluid overload, and access point hemorrhage are among the primary growth-restraining variables for the market that could impede the growth of hemodialysis and peritoneal dialysis. These issues also pose a threat to the industry's expansion.
COVID Impact
The COVID-19 pandemic had a positively impact on the Hemodialysis and Peritoneal Dialysis market. As Serious sickness is more likely to strike the elderly and those with underlying health issues. Due to their constant pre inflammatory state and functional deficiencies in innate and adaptive immunity, patients with chronic kidney disease (CKD) are more likely to contract respiratory tract infections and pneumonia. Because of this, people with kidney disease, those undergoing transplant surgery, and people with other serious chronic medical problems are more prone to have serious COVID-19-related effects. According to the National Kidney Foundation, 15% of patients hospitalized for COVID-19 have acute renal impairment, and many of these patients need dialysis. Dialysis patients may struggle more to fight infections because of their compromised immune systems. Due to the availability of knowledgeable professionals, in-center dialysis is frequently chosen by patients, and as a result, guidelines for managing COVID-19 outbreaks in dialysis units were subsequently created. Also, the dialysis rooms for COVID-19 patients and regular patients are kept separate some hospitals are using shifts.
Regional Trend
Geographically, North America dominated the Hemodialysis and Peritoneal Dialysis market and had the largest revenue share of 89% in 2021. The growth in this region can be attributed to due to the increasing prevalence of chronic kidney disease and healthcare spending by Medicare are contributing to the growth of the market in the country. A well-developed and increasing R&D and escalating adoption of technological advancement in infusion pumps contributed to the growth the of Hemodialysis and Peritoneal Dialysis in this region. The U.S. held the biggest market share of the North America Hemodialysis and Peritoneal Dialysis market due to rise in disease prevalence, huge medical R&D investments and a strong healthcare system. The increase in incidences of kidney failure in the U.S. is also a key significant factor, more than 500,000 patients have undergone dialysis and more than 200,000 people are living with a kidney transplant, which can be attributed to their lifestyle & stressed work environment.
Over the projection period, the Asia Pacific area is anticipated to have significant expansion. A growing number of people in Asia are living with chronic illnesses like cancer, diabetes, and dialysis. Asian nations with developing economies, such as Japan, China, and India, have developed healthcare infrastructure and amenities.
Competitive Landscape
Key players operating in the Hemodialysis and Peritoneal Dialysis Market include 3M Company, Allmed Medical Care Holdings Limited, Angiodynamics Inc., Asahi Kasei Medical Co., Ltd., Atlantic Biomedical, Baxter International Inc., C. R. Bard, Inc., B. Braun Melsungen Ag, Cook Group, DaVita Inc., Dialifegroup, Diaverum, Fresenius SE and Co. KGAA, Isopure Corp., JMS Co. Ltd., Mar Cor Purification, Medtronic Plc., Nikkiso Co. Ltd., Nipro Corporation, Nxstage Medical, Inc., and Rockwell Medical among others. With its innovative hemodialysis machine that attempts to prevent blood clotting without the need of any medication, Fresenius Medical Care's new hemodialysis system was given a breakthrough device designation by the U.S. FDA in October 2019. Furthermore, a select few major businesses are launching technologically upgraded items to gain a competitive edge in the market.
Key USP’s-
The National Kidney Foundation estimates that in 2018, there were 785,883 Americans who had renal failure, of whom 554,038 required dialysis. Similar to adults, the FDA reports that roughly 10,000 kids in the US get acute AKI. The survival rate for these kids ranges from 38% to 43%. For newborns with AKI, the mortality rate is about 60%.
Market Segmentation
Based upon the Types used in the Hemodialysis and Peritoneal Dialysis market is segmented in Hemodialysis and Peritoneal dialysis. With a revenue share of over 85%, the market was dominated by the hemodialysis category, which is anticipated to grow at the highest CAGR over the projected period. The hemodialysis market is also further divided into nighttime hemodialysis and typical, brief daily hemodialysis. Continuous Ambulatory Peritoneal Dialysis (CAPD) and Ambulatory Peritoneal Dialysis are two further subgroups of peritoneal dialysis (APD). Based on the Product, the Hemodialysis and Peritoneal Dialysis market is segmented into Device, Consumables and Services. In the product segment with a share of more than 55.0%, the service category controlled the market. Both the prevalence of ESRD and the availability of dialysis services have increased, which may be related to this. In addition, a number of significant dialysis service providers are attempting to diversify their service portfolios by opening and acquiring new dialysis facilities around the globe, which is anticipated to stimulate segment expansion.
End user segment of Hemodialysis and Peritoneal Dialysis market is further bifurcated into Hospitals & Clinics and Home Healthcare. With a market share of more than 80.0%, the hospital-based segment controlled the market. In the upcoming years, the business will probably be able to keep its advantage thanks to the large number of highly qualified and experienced healthcare personnel available at hospitals. The presence of a skilled and knowledgeable renal care team in healthcare settings including hospitals and dialysis clinics ensures successful treatment and enhanced dialysis results.
By Type
• Hemodialysis
o Conventional hemodialysis
o Short daily hemodialysis
o Nocturnal hemodialysis
• Peritoneal dialysis
o Continuous Ambulatory Peritoneal Dialysis (CAPD)
o Automated Peritoneal Dialysis (APD)
By Product
• Device
o Machine
o Dialyzer
o Water treatment system
o Others
• Consumables
o Bloodline
o Concentrates
o Catheters
o Others
• Services
By End User
• Hospitals & Clinics
• Home Healthcare